Unclassifiable Interstitial Lung Disease: Update on Challenges and Successes

Listen as faculty review the signs, symptoms, laboratory, histopathologic, and image findings that lead to better diagnosis of uILD. Review treatment strategies for managing patients with uILD and hear expert perspectives on the clinical trial findings of emerging treatments.
Toby Maher, MD, PhD, FRCP
Mary Beth Scholand, MD
Released: August 5, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings